Preprint Concept Paper Version 1 Preserved in Portico This version is not peer-reviewed

Microglial Replacement and COURIER or SPIT for Neuronal Gene Editing

Version 1 : Received: 24 April 2024 / Approved: 24 April 2024 / Online: 24 April 2024 (11:05:05 CEST)

How to cite: Renteln, M. Microglial Replacement and COURIER or SPIT for Neuronal Gene Editing. Preprints 2024, 2024041620. https://doi.org/10.20944/preprints202404.1620.v1 Renteln, M. Microglial Replacement and COURIER or SPIT for Neuronal Gene Editing. Preprints 2024, 2024041620. https://doi.org/10.20944/preprints202404.1620.v1

Abstract

Adeno-associated viral (AAV) vectors can be used for gene delivery. AAV.CAP-Mac was recently developed; it can cross the blood-brain barrier and transduce cells throughout the CNS. However, some brain regions were not transduced in adult rhesus monkeys. Additionally, AAV vectors can only package 5 kb of DNA. Also, AAV vectors may be genotoxic and cytotoxic, especially at high doses. Finally, AAV vectors are very expensive to produce at sufficiently high titers for treatment. Off-the-shelf cell-based delivery systems wherein the cells can infiltrate the target tissue and be hyper-motile would be ideal. Also, mRNA-based gene editing would be a transient treatment, and thus be much safer.

Keywords

microglial replacement; adeno-associated viral (AAV) vectors; COURIER; SPIT; base editing; prime editing

Subject

Biology and Life Sciences, Biology and Biotechnology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.